Lara Stepan
Impact in
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
- Oncology top 5%
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
Papers in
- Oncology 6
- CAR-T cell therapy research 6
- Cancer Cells and Metastasis 1
- Co-authors
- Luís Borges (2 shared papers)Claire L. Sutherland (2 shared papers)Esther S. Trueblood (1 shared paper)John S. Babcook (1 shared paper)Kari Hale (1 shared paper)Koji Izutsu (3 shared papers)K. OGASAWARA (3 shared papers)Manali Kamdar (3 shared papers)
- Journals
- Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (1 paper)The Lancet (1 paper)International Journal of Cancer (1 paper)Blood (1 paper)Cancer Medicine (1 paper)
- Partner nations
- United StatesSwitzerlandJapan
In The Last Decade
Lara Stepan
8 papers receiving 765 citations
Lara Stepan's Hit Papers
Peers
Comparison fields: 5 of 65
- Biological Psychiatry 82
- Oncology 529
- Behavioral Neuroscience 35
- Pathology and Forensic Medicine 168
- Immunology 114
Countries citing papers authored by Lara Stepan
This map shows the geographic impact of Lara Stepan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara Stepan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara Stepan more than expected).
Fields of papers citing papers by Lara Stepan
This network shows the impact of papers produced by Lara Stepan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara Stepan. The network helps show where Lara Stepan may publish in the future.
Co-authors
The 25 scholars most cited alongside Lara Stepan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial Hit paper breakdown → | 2022 | 435 |
| 2 | 2011 | 194 | |
| 3 | 2011 | 94 | |
| 4 | 2022 | 20 | |
| 5 | 2002 | 17 | |
| 6 | 2003 | 9 | |
| 7 | 2024 | 7 | |
| 8 | 2023 | 4 |
About Lara Stepan
Lara Stepan is a scholar working on Oncology, Molecular Biology, Immunology, Pathology and Forensic Medicine and Biological Psychiatry, having authored 8 papers that have together received 780 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Immunotherapy and Immune Responses (2 papers), Integrated Circuits and Semiconductor Failure Analysis (1 paper), Cancer Genomics and Diagnostics (1 paper), Cancer Cells and Metastasis (1 paper), Tryptophan and brain disorders (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Biological Psychiatry (82 citations), Oncology (529 citations), Behavioral Neuroscience (35 citations), Pathology and Forensic Medicine (168 citations) and Immunology (114 citations). Lara Stepan has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Luís Borges, Claire L. Sutherland, Esther S. Trueblood, John S. Babcook, Kari Hale, Koji Izutsu, K. OGASAWARA, Manali Kamdar, Scott R. Solomon and Franck Morschhauser. Their work appears in journals such as Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, The Lancet, International Journal of Cancer, Blood and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.